Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Rysavy

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
JAMA Pediatrics|March 3, 2020
Assessment of an Updated Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford NetworkMatthew A Rysavy, Jeffrey D Horbar, Edward F Bell, et al.
The New England Journal of Medicine|May 7, 2015
Between-hospital variation in treatment and outcomes in extremely preterm infantsMatthew A Rysavy, Lei Li, Edward F Bell, et al.
The Journal of Pediatrics|February 4, 2020
Behavior Profiles at 2 Years for Children Born Extremely Preterm with Bronchopulmonary DysplasiaJane E Brumbaugh, Edward F Bell, Scott F Grey, et al.
JAMA Network Open|February 21, 2025
Short Duration of Antenatal Corticosteroid Exposure and Outcomes in Extremely Preterm InfantsSanjay Chawla, Myra H Wyckoff, Satyan Lakshminrusimha, et al.
JAMA|January 18, 2022
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018Edward F Bell, Susan R Hintz, Nellie I Hansen, et al.
Pediatrics|August 29, 2023
Strengthening Reporting of Neonatal TrialsJames Webbe, Ami Baba, Nancy J Butcher, et al.
Pediatrics|August 29, 2023
Heterogeneity and Gaps in Reporting Primary Outcomes From Neonatal TrialsAmi Baba, James Webbe, Nancy J Butcher, et al.
JAMA|April 28, 2025
Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical TrialWaldemar A Carlo, Eric C Eichenwald, Benjamin A Carper, et al.
JAMA|September 30, 2025
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical TrialNamasivayam Ambalavanan, Waldemar A Carlo, Kayla J Nowak, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 4, 2023
Use of term reference infants in assessing the developmental outcome of extremely preterm infants: lessons learned in a multicenter studyCharles E Green, Jon E Tyson, Roy J Heyne, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
JAMA Pediatrics|March 3, 2020
Assessment of an Updated Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford NetworkMatthew A Rysavy, Jeffrey D Horbar, Edward F Bell, et al.
The New England Journal of Medicine|May 7, 2015
Between-hospital variation in treatment and outcomes in extremely preterm infantsMatthew A Rysavy, Lei Li, Edward F Bell, et al.
The Journal of Pediatrics|February 4, 2020
Behavior Profiles at 2 Years for Children Born Extremely Preterm with Bronchopulmonary DysplasiaJane E Brumbaugh, Edward F Bell, Scott F Grey, et al.
JAMA Network Open|February 21, 2025
Short Duration of Antenatal Corticosteroid Exposure and Outcomes in Extremely Preterm InfantsSanjay Chawla, Myra H Wyckoff, Satyan Lakshminrusimha, et al.
JAMA|January 18, 2022
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018Edward F Bell, Susan R Hintz, Nellie I Hansen, et al.
Pediatrics|August 29, 2023
Strengthening Reporting of Neonatal TrialsJames Webbe, Ami Baba, Nancy J Butcher, et al.
Pediatrics|August 29, 2023
Heterogeneity and Gaps in Reporting Primary Outcomes From Neonatal TrialsAmi Baba, James Webbe, Nancy J Butcher, et al.
JAMA|April 28, 2025
Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical TrialWaldemar A Carlo, Eric C Eichenwald, Benjamin A Carper, et al.
JAMA|September 30, 2025
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical TrialNamasivayam Ambalavanan, Waldemar A Carlo, Kayla J Nowak, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 4, 2023
Use of term reference infants in assessing the developmental outcome of extremely preterm infants: lessons learned in a multicenter studyCharles E Green, Jon E Tyson, Roy J Heyne, et al.
Pageof 7